Sotuvning operatsion marjasi: uniQure Corp (QURE)

uniqure.com (QURE) kompaniyasining korporativ logotipi

uniQure N.V. (QURE) noyob patologiyalar terapiyasi uchun virusli vektorlarga investitsiya kiritayotgan, DNKga asoslangan dori vositalarining yetakchi ishlab chiquvchisidir. Operatsion foyda marjasi samaradorlik dinamikasini aks ettiradi, bunda -1026.90 darajasi muhim mezon bo'lib xizmat qiladi. Elita biologlar jamoasi tadqiqotlarning barqaror rivojlanishini ta'minlaydi, noyob gemofiliya davolash usullari esa FDA ning qat'iy nazorati ostida bemorlarning sodiqligini kafolatlaydi.

uniqure.com (QURE): Operatsion foyda normasi 04.07.2022dan 20.11.2026gacha

uniqure.com (QURE) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning umumiy tahlili:uniQure NV, QURE
uniQure N.V. tayyor mahsulotlari

Operatsion marja umumiy daromadga nisbatan foizlar va soliqlar to'lanishidan oldingi asosiy operatsiyalardan olingan foyda ulushini o'lchaydi. Operatsion marja tendentsiyasini tahlil qilish orqali investor xarajatlarni boshqarishning ichki samaradorligini baholaydi. Ushbu ko'rsatkich operatsion foydaning savdolarga nisbati sifatida hisoblanadi va biznes yadrosining daromadliligini aks ettiradi. uniQure N.V. (QURE) uchun bu terapevtik vektorlarning murakkab logistikasi xarajatlarini qamrab oladi. AQSh va Yevropa o'rtasidagi ortiqcha yo'nalishlarni optimallashtirish ushbu ko'rsatkichga bevosita ta'sir ko'rsatadi.

Asosiy raqobatchilar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik